CSIMarket
 
Strongbridge Biopharma plc  (SBBP)
Other Ticker:  
 
 

Strongbridge Biopharma Plc Growth Comparisons

Select each growth Category to receive further Information



SBBP Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q2 MRQ) 29.41 % 30.87 % 26.96 % 32.25 %
Q / Q Revenue Growth (Q2 MRQ) 19.8 % 8.94 % 6.72 % 5.39 %
Y / Y Revenue Growth (for 12 months ending Q2 TTM) 34.98 % 19.28 % 17.13 % %
Seq. Revenue Growth (for 12 months ending Q2 TTM) 7.03 % 6.77 % 5.08 % 6.95 %
Revenue 5 Year Average Growth - 13.17 % 9.84 % 7.66 %


SBBP's Growth Comparisons in II. Quarter 2021




Strong but slowing Revenue rise by Strongbridge Biopharma Plc of 29.41% from the same quarter a year ago, in the second quarter 2021 to 10 millions, was lower than the 30.87% improvement in the Major Pharmaceutical Preparations industry, but beating the 26.96% increase in the Healthcare sector. Slow second quarter sales, in the Major Pharmaceutical Preparations industry and Healthcare sector, were portrayed in Strongbridge Biopharma Plc results which underperformed overall market.

Top-line improved by 19.8% from the first quarter. Looking into annual sales rise of %, and S & P 500's average yearly sales growth is 7.66% over the five years, including only Businesses with the second quarter 2021 Results. Strongbridge Biopharma Plc grew less than the market.


Growth Rates of SBBP's Income in the second quarter 2021


SBBP Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q2 MRQ) - 70.82 % 162.92 % 143.25 %
Seq. Operating Income Change (Q2 MRQ) - 0.42 % 5.62 % 2.82 %
Y / Y Operating Income Growth (Q2 TTM) - -17.51 % 28.23 % 33.04 %
Seq. Operating Income Growth (Q2 TTM) - 20.4 % 24.78 % 22.34 %
Operating Income 5 Year Avg. Change - 7.86 % 2.77 % 8.56 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q2 MRQ) - 81.78 % 334.98 % 250.54 %
Seq. Income from Cont. Ops. Change (Q2 MRQ) - -3.26 % 4.55 % 3.25 %
Y / Y Income from Cont. Ops. Change (Q2 TTM) - -0.55 % 35.58 % 57.05 %
Seq. Income from Cont. Ops. Change (Q2 TTM) - 23.16 % 37.55 % 29.09 %
Income from Cont. Ops. 5 Year Avg. Change - 7.18 % 3.17 % 1.63 %

SBBP Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q2 MRQ) - 86.18 % 385.35 % 278.45 %
Q / Q Net Income Growth (Q2 MRQ) - -1.09 % 5.51 % 9.61 %
Y / Y Net Income Change (Q2 TTM) - 1.02 % 37.79 % 61.81 %
Seq. Net Income Change (Q2 TTM) - 24.25 % 40.25 % 31.91 %
Net Income 5 Year Avg. Growth - 9.06 % 3.52 % 1.93 %

SBBP's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q2 MRQ) - 77.26 % 334.98 % 250.54 %
Seq. EPS from Cont. Ops. Change (Q2 MRQ) - -9.37 % 4.55 % 3.25 %
Y / Y EPS from Cont. Ops. Change (Q2 TTM) - - - -
Seq. EPS from Cont. Ops. Change (Q2 TTM) - -0.05 % -0.05 % 17688.28 %
EPS from Cont. Ops. 5 Year Avg. Growth - -21.44 % 3.17 % 1.63 %



SBBP EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q2 MRQ) - 81.55 % 385.35 % 1.63 %
Q / Q EPS Net Growth (Q2 MRQ) - -7.34 % 5.51 % 9.61 %
Y / Y EPS Net Change (for 12 months ending Q2 TTM) - - - 14997.19 %
Seq. EPS Net Change (for 12 months ending Q2 TTM) - - - 18042.19 %
EPS Net 5 Year Avg. Change - 9.06 % 3.52 % 1.93 %



Strongbridge Biopharma Plc reported bottom-line of $ -0.21 in the second quarter, compare to $ -0.32 in the same quarter a year ago. Major Pharmaceutical Preparations industry grew by 81.55%, while Healthcare sector increased by 385.35%, and overall market improved by 278.45%.

The bottom-line improved by 19.8% from the first quarter. Looking into annual income per share rise of %, and S & P 500's average yearly income per share growth is 1.93% over the five years, including only Businesses with the second quarter 2021 earnings reports. Strongbridge Biopharma Plc grew less than the market.

SBBP Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q2 MRQ) - 21.4 % 1.82 % 25.63 %
Seq. Free Cash Flow Change (Q2 MRQ) - 41.75 % 21.01 % 83.3 %
Y / Y Free Cash Flow Change (Q2 TTM) - 19.19 % 16.27 % -3.7 %
Seq. Free Cash Flow Change (Q2 TTM) - 3.87 % 0.98 % 8.06 %
Free Cash Flow 5 Year Avg. Change - 15.68 % 13.37 % 18.08 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q2 MRQ) - -50.93 % 4.53 % -
Seq. Net Cash Flow Change (Q2 MRQ) - - - -
Y / Y Net Cash Flow Change (Q2 TTM) 34.34 % -88.3 % -83.34 % -83.46 %
Seq. Net Cash Flow Change (Q2 TTM) - -89.32 % 57.71 % -71.83 %
Net Cash Flow 5 Year Avg. Change -3.26 % 45.94 % 52.53 % 121.5 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q2 MRQ) - 2.96 % 10.24 % 11.3 %
Seq. Capital Expenditures Change (Q2 MRQ) - -1.07 % 0.4 % -2.67 %
Y / Y Capital Expenditures Change (Q2 TTM) -51.22 % 15.05 % 11.27 % -2.9 %
Seq. Capital Expenditures Change (Q2 TTM) 0 % 0.3 % 3.32 % 2.66 %
Capital Expenditures 5 Year Avg. Change - 478.29 % 271.01 % 86.97 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 







Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com